Global Point-of-Care (POC) Diagnostic Market Report and Forecast 2025-2034

Point-of-Care (POC) Diagnostic Market Overview

Point-of-care (POC) diagnostics refer to medical testing conducted near the patient, enabling immediate results and quicker decision-making. These tests are designed to be portable, user-friendly, and efficient, often requiring minimal training to operate. POC diagnostics are commonly used in settings such as clinics, homes, ambulances, or remote areas, eliminating the need to send samples to centralised laboratories. They are vital for rapid detection of conditions like infections, diabetes, or heart diseases, facilitating timely treatment and improving patient outcomes. Examples include glucometers, rapid antigen tests, and blood gas analysers.

Point-of-Care (POC) Diagnostic Market Growth Drivers

Strategic Acquisitions to Enhance Point-of-Care Diagnostic Capabilities 

The increasing demand for rapid diagnostics, driven by the need for immediate healthcare decision-making and decentralised patient care, is boosting the growth of the market. For instance, in January  2025, bioMérieux, a leader in in vitro diagnostics, acquired SpinChip Diagnostics ASA, a Norwegian company specialising in immunoassay platforms for near-patient testing. This acquisition includes a small benchtop analyser capable of delivering results from a whole blood sample within 10 minutes, maintaining laboratory-level sensitivity. The integration of SpinChip’s innovative platform is expected to accelerate bioMérieux’s POC capabilities, fostering faster, high-quality diagnostic testing in decentralised healthcare settings, thereby expanding market opportunities in the forecast period.

Expansion of Multi-Assay Platforms to Accelerate Point-of-Care (POC) Diagnostic Market Demand

The growing need for integrated diagnostic platforms that provide quick, accurate results at the point of care is shaping the market. For instance, in July  2024, Roche completed the acquisition of LumiraDx’s POC technology, which includes a multi-assay platform capable of performing a wide range of immunoassay and clinical chemistry tests. The platform’s potential for expansion into molecular testing further strengthens Roche's portfolio. This acquisition allows Roche to enhance its decentralised diagnostic offerings, broadening access to timely and actionable results for both patients and healthcare providers. The integration of LumiraDx’s technology is expected to boost global market growth, driving wider adoption of POC diagnostic solutions.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Point-of-Care (POC) Diagnostic Market Trends

Point-of-Care (POC) Diagnostic Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Point-of-Care (POC) Diagnostic Market Share

Glucose Monitoring Kits to Lead the Segment by Treatment Type

Glucose monitoring kits will likely hold the largest market share due to the rising prevalence of diabetes and increased focus on diabetes management. These kits provide real-time glucose level tracking, essential for improving patient outcomes and reducing complications. The growing adoption of home-based care and portable devices drives their widespread use. As per the analysis  by Expert Market Research, the global glucose monitoring devices market is anticipated to grow at a CAGR of 11.3% during the forecast period of 2025-2034. Moreover, continuous innovations, such as integration with smartphone apps and wearable technologies, enhance usability and data tracking. With diabetes cases projected to increase globally, this segment is poised for sustained growth, contributing significantly to the overall expansion of the point-of-care diagnostic market.

Infectious Diseases Testing Kits to Lead the Point-of-Care (POC) Diagnostic Market Segmentation by Indication Type

Infectious disease testing kits are expected to dominate the market by indication type due to increasing demand for rapid and accurate diagnostic tools during outbreaks like COVID-19. These kits enable immediate identification of pathogens, improving disease control and treatment efficacy. Their importance is amplified in resource-limited settings, where timely diagnosis is crucial. Technological advancements, including molecular diagnostics and multiplex testing, have further boosted their efficiency and adoption. Government initiatives and global health programmes targeting infectious disease management continue to drive growth. 

Hospitals/Critical Care Centres to Hold Significant Point-of-Care (POC) Diagnostic Market Value for End User Segmentation

Hospitals and critical care centres represent a notable market share among end users due to their high diagnostic testing volumes and advanced infrastructure. These facilities rely on POC diagnostics for emergency, inpatient, and critical care settings, where rapid results significantly influence clinical decisions. The integration of point-of-care devices into hospital workflows enhances efficiency, particularly in managing chronic diseases and acute conditions. Increasing investments in healthcare infrastructure and the adoption of sophisticated diagnostic technologies further fuel this segment’s growth. As demand for advanced healthcare services rises globally, hospitals and critical care centres will continue driving the POC diagnostic market forward.

Point-of-Care (POC) Diagnostic Market Analysis by Region

North America is expected to hold the largest share of the market, driven by advanced healthcare infrastructure, high adoption of innovative technologies, and robust investments in research and development. The prevalence of chronic diseases like diabetes and cardiovascular conditions further boosts demand for point-of-care testing. Additionally, the region’s supportive regulatory environment facilitates the swift approval of diagnostic devices, while strong reimbursement frameworks enhance accessibility.

Europe is another prominent region, owing to its growing focus on decentralised healthcare and home-based diagnostics. Increased government funding for infectious disease management and early diagnosis, coupled with the rising geriatric population, drives market expansion. The integration of AI in diagnostics and the region’s strong emphasis on preventive healthcare also contribute significantly to growth.

Leading Players in the Point-of-Care (POC) Diagnostic Market

Other key players in the market include Siemens AG, Danaher Corp as well as Becton, Dickinson and Company. 

Key Questions Answered in the Point-of-Care (POC) Diagnostic Market

• What was the global point-of-care (POC) diagnostic market value in 2034? 
• What is the point-of-care (POC) diagnostic market forecast outlook for 2025-2034?
• What is market segmentation based on product?
• How is the market segmented based on platform?
• How is the market segmented based on modes of purchase?
• How is the market segmented based on the end users?
• What are the major factors aiding the point-of-care (POC) diagnostic market demand?  
• How has the market performed so far and how is it anticipated to perform in the coming years? 
• What are the market's major drivers, opportunities, and restraints?
• What are the major point-of-care (POC) diagnostic market trends?
• Which product will lead the market segment?  
• Which platforms will lead the market segment?  
• Which mode of purchase will lead the market segment?  
• Which end user will lead the market segment?  
• Who are the key players involved in the point-of-care (POC) diagnostic market? 
• What is the patent landscape of the market? 
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?